The Research Progress on the Improvement and Safety of Steviol Glycosides in Dyslipidemia of Diabetic Rats

Steviol glycosides, as natural sweeteners, are highly favored in the market. Moreover, they have shown outstanding effects in improving dyslipidemia. Most diabetic patients experience dyslipidemia, significantly increasing their risk of cardiovascular diseases. Steviol glycosides can improve dyslipidemia in rats by enhancing lipid metabolism, improving insulin conditions, and exhibiting antioxidant and anti-inflammatory properties. There have been no reports of toxicity or allergic reactions from the use of steviol glycosides in the past, and extensive research currently confirms their safety. Therefore, steviol glycosides hold promise as an adjunct medicinal food for improving dyslipidemia in diabetic patients, promoting their application in the medical and food industries.